US FDA Keeps Estimate For NDI Notification Burden At Level Supplement Industry Doubts

FDA again sets expected costs at level supplement industry repeatedly has said drastically underestimates spending on preparing and submitting NDI notifications. But FDA says developing scientific evidence to support a notification is separate from submitting the information to the agency.

two couple are showing half full and half empty side of water glass with their fingers

Another year, another US Food and Drug Administration estimate of costs for new dietary ingredient notifications that the dietary supplement industry says inaccurately parses compliance with the regulation.

The agency on 15 October published a Federal Register notice that once against sets the expected costs at a level...

More from Regulation

More from Policy & Regulation